Streetbeat News

SIG

Signet Jewelers Limited

https://www.signetjewelers.com

Industry

Luxury Goods

Signet Jewelers Limited operates as a diamond jewelry retailer. It operates through three segments: North America, International, and Other. The North America segment operates jewelry stores in jewelry stores in malls, mall-based kiosks, and off-mall locations in the United States and Canada primarily under the Kay Jewelers, Kay Jewelers Outlet, Jared The Galleria Of Jewelry, Jared Vault, Zales Jewelers, Zales Outlet, Diamonds Direct, James Allen, Banter by Piercing Pagoda, and Peoples Jewellers names, as well as operates online through JamesAllen.com and Rocksbox. The International segment operates stores in shopping malls and off-mall locations primarily under the H.Samuel and Ernest Jones brands in the United Kingdom, Republic of Ireland, and Channel Islands. The Other segment is involved in the purchase and conversion of rough diamonds to polished stones, as well as the provision of diamond polishing services. As of January 29, 2022, it operated 2,854 stores and kiosks. Signet Jewelers Limited is based in Hamilton, Bermuda.

Open

98.01

Mkt cap

4.3B

Volume

496K

High

98.01

P/E Ratio

10.60

52-wk high

112.06

Low

96.58

Div yield

0.01

52-wk low

68.16

Following the Federal Reserve's decision to keep interest rates unchanged, U.S. stocks closed higher, with the Dow Jones jumping 400 points. The CNN Money Fear and Greed index indicated improved market sentiment, remaining in the 'Greed' zone. Signet Jewelers reported disappointing Q4 sales and weak FY25 guidance, causing a 12% drop in its shares. General Mills posted better-than-expected Q4 results. Crude oil inventories fell, contrary to expectations. Sectors like communication services, consumer discretionary, and financials led gains in the S&P 500, while healthcare and energy lagged. Investors are looking forward to earnings from Accenture, FedEx, and NIKE.

Portfolio Pulse from Avi Kapoor

March 21, 2024 | 8:09 am

U.S. stocks rose after the Federal Reserve left interest rates unchanged, with the Dow, NASDAQ, and S&P 500 all posting gains. Industrials and health care sectors saw mixed performance. Several companies experienced significant stock movements, including ETAO International, XTL Biopharmaceuticals, and TruGolf Holdings seeing sharp increases, while Lifecore Biomedical, Aquestive Therapeutics, and Signet Jewelers reported declines. The Fed's decision to maintain rates between 5.25% and 5.5% was anticipated, aligning with investor expectations.

Portfolio Pulse from Avi Kapoor

March 20, 2024 | 7:22 pm

Lifecore Biomedical's shares plummeted by 31.7% after announcing the conclusion of its strategic evaluation process, management changes, and board reshuffling. Other stocks experienced significant movements, with gainers like ETAO International and XTL Biopharmaceuticals seeing sharp increases due to a reverse stock split and acquisition news, respectively. Losers included NuScale Power Corporation, which dropped 28% following a downgrade by Wells Fargo, and Ontrak, Inc., which fell 26% after a previous day's surge.

Portfolio Pulse from Avi Kapoor

March 20, 2024 | 6:03 pm

In Wednesday's intraday session, 12 consumer discretionary stocks saw significant movements. Notable gainers included Cazoo Gr (CZOO) with a 62.4% increase, and TCTM Kids IT Education (TCTM) rising by 21.89%. On the losing end, Interactive Strength (TRNR) dropped by 12.1%, and Kaival Brands Innovations (KAVL) fell by 12.0%. Signet Jewelers (SIG) also declined by 10.69% following its Q4 earnings report.

Portfolio Pulse from Benzinga Insights

March 20, 2024 | 5:31 pm

U.S. stocks were mostly flat as markets awaited the Federal Reserve's interest rate decision. Industrials shares rose by 0.5%, while energy shares fell by 0.6%. Crude oil inventories in the U.S. declined, contrary to market expectations. ETAO International announced a reverse stock split, XTL Biopharmaceuticals plans to acquire The Social Proxy, and TruGolf Holdings expanded its AI technology licensing agreement. Lifecore Biomedical concluded its strategic evaluation, Aquestive Therapeutics priced a public offering, and Signet Jewelers reported disappointing sales and guidance.

Portfolio Pulse from Avi Kapoor

March 20, 2024 | 4:47 pm

Telsey Advisory Group analyst Dana Telsey reiterated a 'Market Perform' rating on Signet Jewelers (NYSE:SIG) and maintained a $105 price target.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 1:31 pm

In Wednesday's pre-market session, consumer discretionary stocks saw significant movements. PDD Holdings led the gainers with a 17.6% increase following their Q4 earnings release, while Signet Jewelers experienced the largest drop among the losers, declining by 11.5% also after their Q4 earnings report. Other notable movements included Vision Marine and Topgolf Callaway Brands with substantial gains, and Interactive Strength and Chijet Motor Co among the notable losers.

Portfolio Pulse from Benzinga Insights

March 20, 2024 | 1:06 pm

US stock futures indicate a cautious opening as investors await the Federal Reserve's interest rate decision. Weak bond yields and gold prices suggest expectations of a dovish Fed stance. The S&P 500 showed signs of a near-term top, with potential for a 5-6% pullback. Premarket trading saw SPY and QQQ ETFs move slightly, while individual stocks like BNTX, PDD, JKS, NDAQ, and CMG saw significant premarket activity due to earnings and announcements.

Portfolio Pulse from Shanthi Rexaline

March 20, 2024 | 11:28 am

Signet Jewelers' stock price declined following the announcement of disappointing Q4 sales and weaker than anticipated fiscal year 2025 guidance.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 11:22 am

Signet's Board of Directors has approved an expansion of the remaining multi-year repurchase authorization by $200 million. This decision indicates the company's confidence in its financial health and future prospects, potentially signaling a positive outlook to investors.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 11:01 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.